Capillary Biomedical closes $2.9 million seed round
Capillary Biomedical Inc. has raised $2.9 million in a seed funding that will help it bring its diabetes management technology to market.
The round was led by the Cove Fund with participation by a syndicate of Angel Groups and accredited investors.
Irvine, California-based Capillary Biomedical said it plans to use the funds for clinical studies to support regulatory clearance and preparation for commercial launch in 2019.
CapBio i s developing a novel infusion set for use with insulin pumps for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news
More News: Diabetes | Endocrinology | Funding | Health Management | Insulin | Pharmaceuticals | Study